- cafead   Mar 31, 2022 at 10:22: AM
via In its first earnings report since it went public, Pear Therapeutics met its guidance for 2021. The company, which makes digital therapeutics for substance use and insomnia, merged with a special-purpose acquisition company (SPAC) in December. The company brought in $4.2 million in revenue for the year, above its $4 million guidance, and also beat milestones for the number of prescriptions and covered lives.
article source
article source